Hodgkin’s lymphoma Rakesh Biswas

Slides:



Advertisements
Similar presentations
HODGKIN LYMPHOMA IN CHILDREN
Advertisements

Non Hodgkin’s lymphoma
A lump in the neck Lent term year 2.
Lymphoma Ismail M. Siala.
Hodgkin’s Disease (HD)
HAEMATOLOGY MODULE: LYMPHOMA Adult Medical-Surgical Nursing.
Hodgkin lymphoma Histologic subtypes: - Nodular sclerosing - Mixed cellularity - Lymphocyte predominance -Lymphocyte depleted new category: - Lymphocyte.
LYMPHOMAS By DR : Ramy A. Samy.
Clinical Management of Lymphoma 新光醫院 血液腫瘤科 溫 武 慶.
Lymphomas Ismail M. Siala.
Hodgkin Disease Definition: neoplastic disorder with development of specific infiltrate containing pathologic Reed-Sternberg cells. It usually arises in.
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
Focusing on Hodgkin Disease
Educational Presentation. Program Overview Provide information on The Leukemia & Lymphoma Society Describe blood cancers Explain Pennies for Patients.
 B cell neoplasms  T/NK cell neoplasms  Hodgkin lymphoma (disease)
Chronic lymphocytic leukemia (1)
PBL 6 – Lymphoma and leukemia
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Lymphoma DR: Gehan Mohamed.
Breast Cancer By George Rezk.
Non-Hodgkin’s lymphomas-definition and epidemiology
NRS 220 Alterations in Cellular Metabolism.  MDS is a group of disorders that is caused by the formation of abnormal cells in the bone marrow which can.
Lymphoma David Lee MD, FRCPC. Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of.
Lymphoma. ALLMMCLLLymphomas Hematopoietic stem cell Neutrophils Eosinophils Basophils Monocytes Platelets Red cells Myeloid progenitor Myeloproliferative.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
(Relates to Chapter 31, “Nursing Management: Hematologic Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Treatment Planning Hodgkin Lymphoma.
GASTRIC LYMPHOMAS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Edward Camacho Mina 1061 MD4 WINDSOR UNIVERSITY HODGKIN LYMPHOMA.
Hodgkin’s Lymphoma By: Tonya Weir and Paige Mathias Date: October 13, 2010.
Cancer By: Erionne. What is Cancer Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you.
 Management varies with type of lymphoma and pt factors (co-morbidities, age, performance status, pt preferences)  Goal of tx can be curative, to prolong.
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
The sencond xiangya hospital,central south university
K30 Case Presentation David Andorsky August 26, 2008.
Malignancies of lymphoid cells ↑ incidence in general …. CLL is the most common form leukemia in US: Incidence in 2007: 15,340 Origin of Hodgkin lymphoma.
Associate Professor, & Consultant
Chronic lymphocytic leukemia What is C.L.L. ? a chronic disease one particular type of lymphocyte (B-cells) accumulates. not rapidly growing and proliferating.
Hematology and Hematologic Malignancies
LYMPHOMA Malignant transformation of cell in Lymphatic system There are about 600 Lymph Nodes in the body Spleen and gut also have lymphatic tissue.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
Hodgkin's Lymphoma Joe Cliver. Definition  Hodgkin's lymphoma or formerly known as Hodgkin's disease is a cancer of the lymphatic system, which is part.
APPROACH TO LYMPHOID MALIGNANCIES. Patient Evaluation of ALL Careful history and PE CBC Chemistry studies Bone marrow biopsy Lumbar puncture.
Week 6 BGD: Discussion on Hodgkin’s Lymphoma (Etiology, Immunology, Clinical Features, Staging Evluation, Treatment) Presented to the Department of Medicine.
Educational Presentation
Staging evaluation for NHL Ann Arbor Staging system is applicable to both Hodgkin’s disease and NHL.
Hodgkin’s Lymphoma Hodgkin’s Lymphoma Disease in which malignant (cancer) cells form in the lymph system Type of cancer that develops in.
HODGKIN’S LYMPHOMA. Anemia,bleeding tendency. Hepatosplenomegaly.
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Hematopoetic Cancers. Hematopoesis Leukemia New diagnoses each year in the US: 40, 800 Adults 3,500 Children 21,840 died of leukemia in 2010.
Acute lymphoblastic leukemia in children
Asymptomatic lymphadenopathy Mediastinal mass Systemic symptoms Fever, Pruritus Other nonspecific symptoms and paraneoplastic syndromes Intra-abdominal.
Non-Hodgkin Lymphoma March 13, 2013 Suzanne R. Fanning, DO Greenville Health System.
ABNORMAL WBC’S. A 19 yr old man consults a physician about a 2 cm neck Mass. The patient has no systemic symptoms at that time. The mass is resected and.
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
NON-HODGKIN’S LYMPHOMA
Lymphoma David Lee MD, FRCPC.
NIAZY B HUSSAM Ph.D. Clinical Pharmacy
LYMPHOMA Medrockets.com.
Non-Hodgkin’s Lymphoma
Rob Corbett NCCN Christchurch
Dr.Hussein Alatabi MBChB,DCH,FICMS,CABP
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
MLAB Hematology Keri Brophy-Martinez
Leukemia case #9 Hello lovely girl وداد ابو رمضان حليمة نوفل
Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
Lymphomas.
Presentation transcript:

Hodgkin’s lymphoma Rakesh Biswas MD, Professor, Department of Medicine, People's College of Medical Sciences, Bhanpur, Bhopal, India

A 25 year old lady 1 month of evening rise of temperature, night sweats and noticed a lump in her neck On examination pallor, generalized lymphadenopathy, hepatosplenomegaly Case history Possibilities, approach to management

I wasn't feeling well, still couldn't shake the cold that had been plaguing me for what seemed like months. But all in all, not feeling too bad, either. Case history

It is required that anybody teaching in the schools have a clear tuberculosis record. After waiting several minutes, the nurse read my test site. She said it seemed to her there was a little swelling that shouldn't be there, and she asked me to wait and see the doctor. Case history

I started to get a little bit nervous, I mean, Tuberculosis I started to get a little bit nervous, I mean, Tuberculosis? Was that possible? The doctor brought me into her room and she examined me, and she said she could feel tumors in my neck. Had I noticed them? Case history

Lymphoma Clonal malignant disorders that are derived from lymphoid cells: either precursor or mature T-cell or B-cell Majority are of B- cell origin Divided into 2 main types : 1. Hodgkin’s lymphoma 2. Non - Hodgkin’s lymphoma

Hodgkin’s Disease Histologically & clinically a distinct malignant disease Predominantly, B-cell disease Course of the disease is variable, but the prognosis has improved with modern treatment

Etiology ? Infection – EBV ? Environmental factors

REAL* Classification Classic: Non-Classic Nodular Sclerosis Lymhocyte rich Mixed Cellularity Lymhocyte depleted Non-Classic Nodular Lymphocyte predominant *REAL – Revised European,American,lymphoma

Clinical features Bimodal age distribution : M > F Lymphadenopathy: young adults ( 20-30 yrs) & elderly (> 50yrs) May occur at any age M > F Lymphadenopathy: most often cervical region asymmetrical, discrete painless, non-tender elastic character on palpation ( rubbery) not adherent to skin fluctuate in size

Contiguous spread via the lymphatic chain eg Contiguous spread via the lymphatic chain eg.involvement of abdominal & thoracic LNs Extra nodal disease - rare Hepatospleenomegaly

Constitutional symptoms ( B symptoms ) Night sweats, sustained fever > 38 degree celsius, loss of weight >10% of body weight in 6 mo Fever sometimes cyclical (‘Pel-Ebstein fever’) Pain at the site of disease after drinking alcohol Pallor Pruritis Symptoms of Bulky (>10 cm) disease

A zillion tests were done, blood drawn a zillion times, a zillion questions by a million doctors. Finally it was decided they would have to perform a biopsy on one of the tumors to get a diagnosis. Case history

Investigations CBP : Anemia ( normochromic / normocytic), eosinophilia, neutrophilia, lymphopenia ESR -raised LFT- (liver infil / obs at porta hepatis) RFT- prior to treatment Urate , Ca, LDH - adverse prognosis CXR- mediastinal mass CT thorax / abdomen / pelvis-for staging Other: Gallium scan, PET, Lymphangiography , Laporotomy

LN FNAC / biopsy : Malignant REED-STERNBERG ( RS) Cell: Bi-nucleate cell with a prominent nucleolus. Derived from B cell, at an early stage of differentiation Reactive background of eosinophils, lymphocytes, plasma cells Fibrous tissue

The operation was done on February third, my boyfriend's birthday The operation was done on February third, my boyfriend's birthday. I made him a card out of paper I had… Hard to celebrate your boyfriend's birthday while getting ready to get operated on. Case history

REED-STERNBERG ( RS ) Cell

REED-STERNBERG ( RS) Cell

The X-ray technician came out again, looking for me The X-ray technician came out again, looking for me. "We're not ready for you yet, the Doctors are still reading your chart, but we wanted to make sure you didn't leave. Just wait a few minutes and the doctor will be out to talk to you." Case history

I've read in novels the expression "my heart sank" but I'm not sure I ever really felt that sort of thing until just about then. I'd been telling myself there was nothing to worry about, all was ok, but this was a clear cut sign that something was very. very wrong Case history

>10 cm Bulky disease

Lymphangiography

Staging Stage I : Involvement of single LN region (I) or extra lymphatic site (IAE ) Stage II : Two or more LN regions involved (II) or an extra lymphatic site and lymph node regions on the same side of diaphragm Stage III : Involvement of lymph node regions on both sides of diaphragm, with (IIIE) or without (III) localized extra lymphatic involvement or involvement of the spleen (IIS) or both (IISE) Stage IV : Involvement outside LN areas (Liver, bone marrow) A : Absence of ‘B’ symptoms B : B symptoms present

I had Stage IVb Hodgkin's Disease, a form of cancer of the lymph nodes I had Stage IVb Hodgkin's Disease, a form of cancer of the lymph nodes. Well, it's sort of hard to describe what hearing something like that does. Case history It seemed impossible that the nodes in my neck, and the masses that were supposedly on my lungs were cancer. How could that be? I just was amazed. I said "this is unbelievable." and felt more or less detached, numb.

Treatment RT Chemo BMT / SCT Antibody treatment: Rituximab target CD-20 Supportive

Treatment - Guidelines Indications for RT: Stage I disease Stage II disease with 3 or lesser areas involved For Bulky disease For pressure problems Indications for CT All with B symptoms Stage II disease with >3 areas involved Stage III and IV disease

Treatment Stage IA , Stage IIA with 3 or < 3 areas involved: Radiotherapy Stage IB, Stage II A with > 3 areas , Stage IIB: Chemotherapy every 3-4 weeks, 6-8 cycles; either alone, or in combination with radiotherapy Stage III & IV : Chemotherapy + Radiotherapy ( for bulky disease or palliation of symptoms)

Irradiation fields used in Hodgkin’s Lymphoma

Chemotherapy MOPP : Nitrogen Mustard, Vincristine (Oncovin), Procarbazine, Prednisolone ABVD: Adriamycin, Bleomycin, Vinblastine, Dacarbazine Higher dose for relapse or younger pts with poor prognostic features

After six cycles of chemotherapy, my CT scans still show masses on my chest and in my neck. On July 7, I had a meeting with my doctors, and was told that if I continued with standard chemotherapy, my chances of being cured stand at less than ten per cent. Case history

Prognosis Overall 10 yr survival – 80% In long term survivors there is a risk of secondary malignancy: (leukemia , NHL), Solid tumors- Lung, breast Infections Cardiac, pulmonary, endocrinal abnormalities

International Prognostic Index (IPI) Age Advanced stage disease Performance status Elevated LDH Presence of Extra nodal disease

Non Hodgkin’s lymphoma Incidence is increasing NHL>HD Median age of presentation is 65-70 yrs M>F More often clinically disseminated at diagnosis B-cell-70% ; T-cell-30%

‘1990…Although I had been feeling fine, no different from normal, I was worried about this lump in my neck that I had for several months. I first thought it was just because I had some sort of infection, but it didn't go away. Case history

Clinical features Widely disseminated at presentation Nodal involvement: Painless lymphadenopathy, often cervical region is the most common presentation Hepatospleenomegaly Extranodal : Intestinal lymphoma ( abdominal pain, anemia, dysphagia); CNS ( headache, cranial nerve palsies, spinal cord compression) ; Skin, Testis; Thyroid; Lung Bone marrow (low grade): Pancytopenia

Compression syndrome: Systemic symptoms Sweating, weight loss, itching Metabolic complications: hyperuricemia, hypercalcemia, renal failure Compression syndrome: Gut obstruction Ascites SVC obstruction S/C Compression

'The surgeon took a biopsy of the lump, taking a few cells out with a needle to be looked at under the microscope. When the results came back a few weeks later, he told me that they showed I had non-Hodgkin's lymphoma Case history

Diagnosis and staging Similar to HD plus, Bone marrow aspirate & trephine Immunophenotyping : Monoclonal antibodies directed against specific lymphocyte associated antigens B cell antigens ( CD 19, 20, 22); T cell antigens ( CD 2, 3, 5 & 7) Immunoglobulin determination: Ig G / IgM praprotein marker HIV CT / MRI

Classification REAL Clinical / Working Formulation Low grade Inermediate grade High grade

Classification Staging Low grade Proliferation: Low Course: Indolent Symptoms: -ve Treatment: Not curable High grade High Rapid, fatal(un-Rx) +ve Potentially Curable Staging Similar to HD

Etiology Cannot be attributed a single cause Chromosomal translocations: t (14, 18) Infection: Virus:EBV, HTLV,HHV-8, HIV Bacteria: H.Pylori - Gastric lymphoma Immunology: Congenital immunodeficiency, Immunocompromised patients - HIV, organ transplantation

'When I went back a couple of weeks later, he said that the results showed I had stage I indolent follicular non-Hodgkin's lymphoma, which is a slow-growing form of the disease. He said that the good news was that only one lymph node was affected and that I had no B symptoms. Case history

So, he suggested that I have radiotherapy on the swollen lymph node in my neck to make it go away. Because I had heard so many stories about how radiotherapy can make you sick and your hair fall out, I was quite worried Case history

'In the end, I didn't have any real side effects, apart from feeling a bit tired, and the lump in my neck went away completely. After a check-up a couple of weeks later, the haematologist told me that I should come back every 6 months for another CT scan to make sure that the non-Hodgkin's lymphoma hadn't come back. Case history

Management Low grade: Asymptomatic : No treatment ; Radiotherapy for localised disease (Stage 1); Chemotheraphy: mainstay is Chlorambucil; Initial response good , but repeated relapses, median survival 6-10 yrs; Newer: Fludarabine, 2-CdA (Chlorodeoxyadenosine) Monoclonal antibody: Rituximab SCT/BMT All cells have protein markers on their surface, known as antigens. Monoclonal antibodies are designed in the laboratory to specifically recognise particular protein markers on the surface of some cancer cells. The monoclonal antibody then 'locks' onto this protein. This either triggers the cell to destroy itself or signals to the body's immune system to attack and kill the cancer cell. For example, rituximab, the monoclonal antibody that is used in the treatment of non-Hodgkin's lymphoma, recognises a protein marker known as CD20. CD20 is found on the surface of the abnormal B cells that are found in some of the most common types of non-Hodgkin's lymphoma. When rituximab locks onto CD20 on the surface of a B cell, the cell may be destroyed directly, but also the body's natural defences are alerted. Rituximab effectively targets the lymphoma cells for destruction by the body's immune system, which can now kill the cancer cells. CD20 is also found on the surface of normal B cells, one of the types of white blood cells that circulate in the body. This means that these normal B cells, too, may be destroyed when rituximab is used. However, the stem cells in the bone marrow that develop into B cells do not have CD20 on their surface. Stem cells are therefore not destroyed by rituximab and can go on to replenish the body with healthy B cells. Although the number of mature, normal B cells is temporarily reduced by the treatment, they return to previous levels after the treatment.

In 1994, when I was between my CT appointments, I found another lump in my neck, so I called up the specialist hospital and they told me to come back early for my next scan. At the same time, they did the bone marrow test and the LDH blood test again. Case history

When I went back to see the haematologist, he told me that they had found… …swollen lymph nodes in my chest and my armpit, as well as my neck, …which really worried me, although he said the disease had not spread to my bone marrow. Case history

Aggressive ( high / intermediate grade): Chemotherapy: mainstay CHOP -every 3 weeks, at least 6 cycles Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, Prednisolonone

'We talked about what treatment I should have, and the doctor said that, as I had radiotherapy on my neck before, and now other lymph nodes were involved, I couldn't have the same treatment again. However, he offered me chemotherapy instead, and I was given the treatment over the next six months. Case history

High risk cases with poor prognostic factors or relapse : High dose chemotherapy combined with autologous BMT / SCT Monoclonal antibody With CNS involvement / leukemic relapse : Similar to ALL

Prognosis Low grade : Median survival –10 yrs High Grade: Increasing age, advanced stage, concomitant disease, raised LDH,T- cell phenotype : Poor prognosis Please supply the written feedback…